Abstract :
Urinary tract infections (UTI) are very often encountered in patients with diabetes mellitus. Emergence of resistant bacterial strains in UTI Increases the cost of treatment, morbidity and mortality in diabetic patients.
Aims & Objectives: The study was aimed to determine the prevalence of UTI in diabetic patient and antimicrobial sensitivity of causative agents for early treatment to reduce morbidity and mortality.
Results: Urine samples were taken from 100 proved diabetic patients attending Diabetic Clinic at NMCH, Kota and were subjected to culture and antibiotic susceptibility during September 2018 to August 2019. The overall prevalence of UTI in diabetics was (36%) with female predominance of (38.46 %) and in male with (31.42%). The UTI was common in age group between 20-40 years. E. coli (52.70%) was the most predominant bacterial isolate followed by Klebsiella (19.44%), Pseudomonas (08.33%), Enterococcus (08.33%), Staph. aureus (05.55%), Proteus mirabilis (02.77%) and CONS (02.77%). The most sensitive drug in our study was Imipenem followed by Amikacin for gram negative isolates. All the gram positive isolates were sensitive to Linezolid.
Conclusion: This study provides a baseline data of current scenario of UTI in diabetic patient in our set up which can be utilized to formulate infection control strategies. An on-going study would be beneficial to maintain a track of the UTI prevalence in diabetic patients.
Keyword :
Urinary tract infection, Uropathogen, Diabetic patients.